1 / 26

Approach to a child with weakness

Approach to a child with weakness . Dr. Pushpa Raj Sharma Professor of Child Health Institute of Medicine. Upper Motor Neuron. Lower Motor Neuron Myopathic. Weakness/paresis/paralysis. Pattern of weakness. Sign UMN LMN Myopathic Atrophy - +++ + Fasciculations - +++ -

Mercy
Download Presentation

Approach to a child with weakness

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Approach to a child with weakness Dr. Pushpa Raj Sharma Professor of Child Health Institute of Medicine

  2. Upper Motor Neuron. Lower Motor Neuron Myopathic Weakness/paresis/paralysis

  3. Pattern of weakness Sign UMN LMN Myopathic • Atrophy - +++ + • Fasciculations - +++ - • Tone +++ - +/- • Distribution Regional Segmental Proximal • Tendon reflexes +++ -/-- +/- • Babinski’s sign + - -

  4. Important fact: • When there is a discrepancy between the history and physical findings, it is usually because the patient complains of weakness, whereas symptoms are actually due to other causes. • Child Abuse may be the cause.

  5. Motor Neuron Disease • Asymmetric • Upper and lower motor neurones • Amyotrophic Lateral Sclerosis (ALS) • Sporadic ALS • Hereditary ALS • Superoxide Dismutase; Chromosome 21; Dominant • Other ALS: Recessive & Dominant • Multi-system disorders • ALS with Ophthalmoplegia & Extrapyramidal Disorders • Polyglucosan body disease • Motor neuronopathy with cataracts and skeletal abnormalities • Multiple system atrophy

  6. Motor Neuron Disease • Symmetrical and proximal • SMN: Chromosome 5q; Recessive • Androgen Receptor (Bulbo-spinal Muscular Atrophy): X-linked; Recessive • Hexosaminidase A (Tay-Sachs): Chromosome 15; Recessive • Hand weakness • Bulbar involvement

  7. Motor Neuron Disease • Lower motor neurones only • Distal Lower Motor Neuron (LMN) Syndrome • IgM vs GM1 ganglioside • IgM vs GalNAc-GD1a ganglioside • Also see: Multifocal motor neuropathy • Proximal Lower Motor Neuron Syndromes • Brachial amyotrophic diplegia • ? Associated with IgM vs asialo-GM1 • Rare: Upper > Lower limbs with anti-Hu antibodies

  8. Motor Neuron Disease • Lower Motor Neuron Syndrome without antibodies (PMA) • ALS variants • Hereditary • Sporadic • Focal motor neuron disease • Monomelic Amyotrophy • Paraspinous muscle amyotrophy • Cervical amyotrophy

  9. Motor Neuron Disease • Paraneoplastic motor neuro(no)pathy • Mild weakness: With lymphoma • Severe weakness: With breast cancer • Hopkins' syndrome: Acute post-asthmatic amyotrophy • Polio & Post-polio syndrome • SMN2 (SMNC) deletions • Neurofibromatosis, Type 25

  10. Motor Neuron Disease • Symmetric & Proximal: Hereditary Spinal Muscular Atrophy • SMN: Chromosome 5q; Recessive • Androgen Receptor (Bulbo-spinal Muscular Atrophy): X-linked; Recessive • Hexosaminidase A (Tay-Sachs): Chromosome 15; Recessive

  11. Motor Neuron Disease • Rapid onset • Acute Axonal Motor Neuropathy • (with Campylobacter jejuni or serum IgG vs GM1) • Poliomyelitis • Porphyria • 4 types cause neurologic attacks • Acute intermittent • Variegate Porphyria • Coproporphyria • δ-amino-levulinic acid dehydratase deficiency • Urine: All types produce increased δ-amino-levulinic acid during attacks

  12. Motor Neuron Disease • Painful • Acquired • Others

  13. Motor Neuron Disease • Acquired • Toxic: Lead; Dapsone; Botulism; Tick Paralysis • Infections • Polio • West Nile • Central European encephalitis • Creutzfeld-Jacob • Amyotrophy • Polyneuropathy (± Demyelinating)

  14. Weakness/ paresis/ paralysis indicates the lesions in the upper motor nurone or lower motor neurone or myoneural junction or muscles. Preservation of sensation/ Increased or absent or diminished jerks/ atrophy or hypertrophy indicates the site of lesions.

  15. The major clinical diagnosis associated with AFP (n= 517) * • Guillain-Barre syndrome (30.2%), • Central nervous system infection (16.2%), • Transverse myelitis (10.6%) • Non-polio enterovirus infection (6.2%), • Hypokalaemic paralysis (5.2%). * Hussain IH, Ali S, Sinniah M, Kurup D, Khoo TB, Thomas TG, Apandi M, Taha AM J Paediatr Child Health. 2004 Mar;40(3):127-30

  16. Age distribution of Guillain-Barré syndrome. AIDP=acute inflammatory demyelinating polyradiculoneuropathy; FS=Fisher syndrome Lyu, R.-K. et al. J Neurol Neurosurg Psychiatry 1997;63:494-500

  17. Seasonal distribution of Guillain-Barré syndrome Lyu, R.-K. et al. J Neurol Neurosurg Psychiatry 1997;63:494-500

  18. Recurrent Guillain Barre' Syndrome • Of the 220 patients of acute idiopathic demyelinating polyneuritis (AIDP/GBS) seen over a seven year period, 15 patients (M:F:11:4) had a relapsing course (6.8%). They had 36 episodes at a variable interval of 3 months to 25 yrs. • Taly AB, Gupta SK, Anisya V, Shankar SK, Rao S, Das KB, Nagaraja D, Swamy HS.J Assoc Physicians India. 1995 Apr;43(4):249-52.

  19. Follow-up of AGBS • At a follow-up of 1 year or more, 20 patients recovered and 3 had residua. • Hung PL, Chang WN, Huang LT, Huang SC, Chang YC, Chang CJ, Chang CS, Wang KW, Cheng BC, Chang HW, Lu CH. Pediatr Neurol. 2004 Feb;30(2):86-91. • permanent neurological defects in children under 15 years of age was 1.4/10 million annually • Rantala H, Uhari M, Niemela M. Arch Dis Child. 1991 Jun;66(6):706-8; discussion 708-9.

  20. Subacute Inflammatory Demyelinating Polyneuropathy. • progressive motor and/or sensory dysfunction consistent with neuropathy in more than one limb with time to nadir between 4 and 8 weeks, • electrophysiologic evidence of demyelination in at least two nerves, • no other etiology of neuropathy, and • no relapse on adequate follow-up. Complete recovery was achieved in 69% of cases and partial recovery in others. • Oh SJ, Kurokawa K, de Almeida DF, Ryan HF Jr, Claussen GC.Neurology. 2003 Dec 9;61(11):1507-12.

  21. Chronic Inflammatory Demyelinating Polyradiculoneuropathy • A low frequency of antecedent events. • Weakness accompanied by sensory loss and diminished tendon reflexes • Pain and cranial neuropathies are uncommon • Progressive weakness for two months. • Sladky JT; Ashwal S: Peripheral neuropathies in childre. Pediatric Neurology Principles and Practice. Ed. Swaiman KS; Ashwal S. 3rd ed.1999. Publisher: Mosby

  22. Causes Inflammatory Polyradiculoneuropathy • GB Syndrome 58% • Chronic inflammatory demyelinating polyneuropathy 31% • Associated with collagen vascular disease 7% • Other immune/infectous disorders 4%

  23. HOPKINS' SYNDROME: Acute post-asthmatic amyotrophy • Onset • After acute asthmatic attack: Latency 1 to 18 days • Mild pain: Limb, neck or meningismus • Rapid onset weakness

  24. HOPKINS' SYNDROME: Acute post-asthmatic amyotrophy • Weakness • Single limb; Asymmetric; May be Proximal > Distal • Severity: Mild to severe • Arm or leg • Sensory: Normal

  25. HOPKINS' SYNDROME: Acute post-asthmatic amyotrophy • CSF • Pleocytosis • Protein: ± Increased • MRI: May show signal (T2) in spinal cord • Prognosis: Permanent paralysis

  26. Flaccid or hyper tonicity

More Related